Literature DB >> 945511

Carnitine deficiency of skeletal muscle: report of a treated case.

C Angelini, S Lücke, F Cantarutti.   

Abstract

We studied a 10-year-old girl with an insidious muscle disease beginning at age 7. Muscle biopsy showed that the majority of type I fibers were vacuolated and contained lipid excess. Carnitine deficiency was found in skeletal muscle. The patient was treated with 3.0 gm L-carnitine per day and with a medium-chain triglyceride diet. She showed a rapid improvement and recovery of strength. A muscle biopsy 8 months later showed a decreased lipid content. Oral carnitine replacement represents an effective treatment for the disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945511     DOI: 10.1212/wnl.26.7.633

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

Authors:  Francis B Stephens; Dumitru Constantin-Teodosiu; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

2.  Carnitine deficiency: clinical, morphological, and biochemical observations in a fatal case.

Authors:  A G Engel; B Q Banker; R M Eiben
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-04       Impact factor: 10.154

3.  Autosomal recessive lipid storage myopathy (probable carnitine deficiency).

Authors:  C Almog; K Fried; R Reif; J Zieghelboim; G Lewinsohn
Journal:  J Med Genet       Date:  1979-12       Impact factor: 6.318

4.  [Carnitine deficiency: a treatable cause of cardiomyopathy in children (author's transl)].

Authors:  V Regitz; R J Hodach; A L Shug
Journal:  Klin Wochenschr       Date:  1982-04-15

5.  Successful carnitine treatment in a non-carnitine-deficient lipid storage myopathy.

Authors:  R C Sengers; J A Bakkeren; J M Trijbels; A M Stadhouders; G J Egberink; H J ter Laak; H J Jaspar
Journal:  Eur J Pediatr       Date:  1980-12       Impact factor: 3.183

6.  [Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].

Authors:  T Deufel; I Paetzke; D Pongratz; G Hübner; O H Wieland
Journal:  Klin Wochenschr       Date:  1984-07-16

Review 7.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  L-propionyl-carnitine protects tissues from ischaemic injury in an 'in vivo' human ischaemia-reperfusion model.

Authors:  Giuseppe Maria Andreozzi; Romeo Martini; Rosa Maria Cordova; Alessandra D'Eri
Journal:  Clin Drug Investig       Date:  2002-11       Impact factor: 2.859

9.  "Carnitine deficient" myopathy and cardiomyopathy with fatal outcome.

Authors:  F Cornelio; S Di Donato; D Testa; M Mora; G Gori; D Peluchetti; M Rimoldi
Journal:  Ital J Neurol Sci       Date:  1980-03

10.  Lipid storage myopathy: successful treatment with propranolol.

Authors:  C Martyn; E H Jellinek; J N Webb
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.